MA25.01 EORTC Lung Cancer Group Survey to Define Synchronous Oligometastatic Disease in NSCLC

Journal of Thoracic Oncology - United States
doi 10.1016/j.jtho.2018.08.529
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

P3.08-03 Stereotactic Radiotherapy of Lung Cancer With Synchronous Bilateral Noduli or Oligometastatic Disease

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

MA25.03 Defining Oligometastatic Non-Small Cell Lung Cancer (NSCLC): An Evolving Multidisciplinary Expert Opinion

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Radiotherapy for Oligometastatic Lung Cancer

Frontiers in Oncology
Cancer ResearchOncology
2017English

Surgical Approach in Oligometastatic Non-Small Cell Lung Cancer

Annals of Translational Medicine
Medicine
2018English

OA07.05 Local Ablative Therapy Improves Survival in Patients With Synchronous Oligometastatic NSCLC Harboring EGFR Mutation Treated With EGFR-TKIs

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Keeping Surgery Relevant in Oligometastatic Non-Small Cell Lung Cancer

Journal of Thoracic and Cardiovascular Surgery
Respiratory MedicinePulmonaryCardiovascular MedicineSurgeryCardiology
2019English

Surgical Management of Oligometastatic Non-Small Cell Lung Cancer

Journal of Thoracic Disease
PulmonaryRespiratory Medicine
2016English

Oligometastatic Disease in the Peritoneal Space With Gastrointestinal Cancer

Visceral Medicine
SurgeryGastroenterology
2017English

P3.08-01 Treatment Outcomes in Oligometastatic Disease of Non Small Cell Lung Cancer: A Single Center Experience

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy